1 |
Ehrlich, B. E., Kaftan, E., Bezprozvannaya, S. and Bezprozvanny, I. : The pharmacology of intracellular -release channels. Trends. Pharmacol. Sci. 15(5), 145 (1994).
DOI
ScienceOn
|
2 |
Berridge, M. J. : Inositol trisphosphate and calcium signaling. Nature 361, 315 (1993).
DOI
ScienceOn
|
3 |
Bishara, N. B., Murphy, T. V. and Hill, M. A. : Capacitative entry in vascular endothelial cells is mediated via pathways sensitive to 2 aminoethoxydiphenyl borate and xestospongin C. J. Br. Phamacol. 135, 119 (2002).
DOI
ScienceOn
|
4 |
Prakriya, M. and Lewis, R. S. : Potentiation and inhibition of release-activated channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of receptors. J. Physiol. 536, 3 (2007).
|
5 |
Gyorke, S. and Fill, M. : Ryanodine receptor adaptation; Control mechanism of -induced release in heart. Science 260, 807 (1993).
DOI
|
6 |
Gregory, R. B., Rychkov, G. and Barritt, G. J. : Evidence that 2-aminoethyl diphenylborate is a novel inhibitor of storeoperated channels in liver cells, and acts through a mechanism which does not involve inositol trisphosphate receptors. J. Biochem. 354, 285 (2001).
DOI
ScienceOn
|
7 |
Ma, H. T., Venkatachalam, K., Li, H. S., Montell, C., Kurosaki, T., Patterson, R. L. and Gill, D. L. : Assessment of the inositol 1,4,5-trisphosphate receptor in the activation of transient receptor potential channels and store-operated entry channels. J. Biol. Chem. 276(22), 18888 (2001).
DOI
ScienceOn
|
8 |
Maruyama, T., Kanaji, T., Nakada, S., Kanno, T. and Mikoshiba, K. : 2APB, 2-amino ethoxydiphenyl borate, a membranepenetrable modulator of Ins(1,4,5)-induced release. J. Biochem. 122, 498 (1997).
DOI
ScienceOn
|
9 |
Lipp, P., Laine, M., Tovey, S. C., Burrell, T. K., Berridge, M. J., Li, W. and Bootman, M. D. : Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart. Curr. Biol. 10, 939 (2000).
DOI
ScienceOn
|
10 |
Perez, P. J., Ramos-Franco, J., Fill, M. and Mignery, G. A. : Identification of functional reconstitution of the type 2 inositol 1,4,5-trisphosphate receptor from ventricular cardiac myocytes. J. Biol. Chem. 272(38), 23961 (1997).
DOI
ScienceOn
|
11 |
Smith, J. S., Imagawa, T., Ma, J., Fill, M., Campbell, K. P. and Coronado, R. : Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J. Gen. Physiol. 92, 1 (1988).
DOI
ScienceOn
|
12 |
Furuichi, T., Kohda, K., Miyawaki, A. and Mikoshiba, K. : Intracellular channels. Curr. Opin. Neurobiol. 4(3), 294 (1994).
DOI
ScienceOn
|
13 |
Woo, S. H., Cleemann, L. and Morad, M. : Ca2+ current-gated focal and local release in rat atrial myocytes: Evidence from rapid 2-D confocal imaging. J. Physiol. 543, 439 (2002).
DOI
ScienceOn
|
14 |
Zhou, Y. Y., Wang, S. Q., Zhu, W. Z., Chruscinski, A., Kobilka, B. K., Ziman, B., Wang, S., Lakatta, E. G., Cheng, H. and Xiao, R. P. : Culture and adenoviral infection of adult mouse cardiac myocytes: Methods for cellular genetic physiology. Am. J. Physiol. Heart. Circ. Physiol. 279, H429 (2000)
DOI
|
15 |
Li, X., Zima, A. V., Sheikh, F., Blatter, L. A. and Chen, J. : Endothelin-1-induced arrhythmogenic signaling is abolished in atrial myocytes of inositol 1,4,5-trisphosphate ()-receptor type 2-deficient mice. Circ. Res. 1274 (2005).
|
16 |
Taylor, C. W. and Broad, L. M. : Pharmacologial analysis of intracellular signaling. Problems and pitfalls. TiPS 19, 370 (1998).
|
17 |
De Smet, P., Parys, J. B., Callewaert, G., Weidema, A. F., Hill, E., De Smedt, H., Erneux, C., Sorrentino, V. and Missiaen, L. : Xestospongin C is an equally potent inhibitor of the inositol 1,4,5-trisphosphate receptor and the endoplasmicreticulum pumps. Cell Calcium. 26(1/2), 9 (1999).
DOI
|